1, 2, 3-Triazole-containing hybrids as leads in medicinal chemistry: A recent overview

K Bozorov, J Zhao, HA Aisa - Bioorganic & medicinal chemistry, 2019 - Elsevier
Abstract The 1, 2, 3-triazole ring is a major pharmacophore system among nitrogen-
containing heterocycles. These five-membered heterocyclic motifs with three nitrogen …

1, 2, 3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships

Z Xu, SJ Zhao, Y Liu - European journal of medicinal chemistry, 2019 - Elsevier
Anticancer agents are critical for the cancer treatment, but side effects and the drug
resistance associated with the currently used anticancer agents create an urgent need to …

1, 2, 3-Triazole-containing compounds as anti–lung cancer agents: Current developments, mechanisms of action, and structure–activity relationship

T Liang, X Sun, W Li, G Hou, F Gao - Frontiers in pharmacology, 2021 - frontiersin.org
Lung cancer is the most common malignancy and leads to around one-quarter of all cancer
deaths. Great advances have been achieved in the treatment of lung cancer with novel …

Cyanoacetohydrazide linked to 1, 2, 3-triazole derivatives: A new class of α-glucosidase inhibitors

A Iraji, D Shareghi-Brojeni, S Mojtabavi… - Scientific Reports, 2022 - nature.com
In this work, a novel series of cyanoacetohydrazide linked to 1, 2, 3-triazoles (9a–n) were
designed and synthesized to be evaluated for their anti-α-glucosidase activity, focusing on …

Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking …

İ Şahin, M Çeşme, FB Özgeriş, F Tümer - Chemico-Biological Interactions, 2023 - Elsevier
In this study, eight new compounds (7a-h) based on triazole compounds containing ester
groups were synthesized with high yields. The structures of the synthesized compounds (7a …

Design, synthesis and in vitro biological evaluation of quinazolinone derivatives as EGFR inhibitors for antitumor treatment

Y Le, Y Gan, Y Fu, J Liu, W Li, X Zou… - Journal of enzyme …, 2020 - Taylor & Francis
In this paper, a series of novel 3-methyl-quinazolinone derivatives was designed,
synthesised and evaluated for antitumor activity in vitro on wild type epidermal growth factor …

An overview of recent advances in the applications of click chemistry in the synthesis of bioconjugates with anticancer activities

K Mashayekh, P Shiri - ChemistrySelect, 2019 - Wiley Online Library
The click chemistry is one of the most powerful C− N bond forming‐reactions towards five‐
membered heterocycles. The copper‐catalyzed azide‐alkyne cycloaddition (CuAAC) has …

1, 2, 3-triazole derivatives with anti-breast cancer potential

X Wu, J Wang, S Xia, S Cheng… - Current Topics in …, 2022 - ingentaconnect.com
Breast cancer is one of the most prevalent malignant diseases, and one of the main causes
of mortality among women across the world. Despite advances in chemotherapy, drug …

Identification and exploration of quinazoline-1, 2, 3-triazole inhibitors targeting EGFR in lung cancer

S Kumar, S Sengupta, I Ali, MK Gupta… - Journal of …, 2023 - Taylor & Francis
Epidermal growth factor receptor (EGFR) enhances lung cancer development, due to their
inability to permeate the cell membrane, secreted growth factors work through specialized …

Visible light-mediated synthesis of quinazolinones from benzyl bromides and 2-aminobenzamides without using any photocatalyst or additive

S Huang, L Jin, Y Liu, G Yang, A Wang, Z Le… - Organic & …, 2024 - pubs.rsc.org
This paper reports a novel method for the visible-light-mediated synthesis of quinazolinones
from the reaction of benzyl bromides with 2-aminobenzamides. The reaction proceeded …